Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Gastrointestinal 1CNS 1Breast 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 11Lenalidomide 10Bortezomib 10Zoledronic Acid 8ixazomib 4daratumumab 4Thalidomide 4Melphalan 4Cyclophosphamide 4tocilizumab 3Prednisone 3pomalidomide 2carfilzomib 2Kyphoplasty 2Filgrastim 2Doxorubicin 2Calcium Dobesilate 2zanubrutinib 1talquetamab 1pegylated granulocyte colony-stimulating factor 1montelukast 1isatuximab 1ibrutinib 1fludarabine phosphate 1fludarabine 1exifone 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1apixaban 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Neoadjuvant Therapy × Plasma cell × Clear all
NCT01868828 2013-06-06

A Study of PAD Versus Velcade, Cyclophosphamide and Dexamethasone (VCD) Treatment in Subjects With Multiple Myeloma

Peking University People's Hospital

Phase 4 Unknown
50 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡